Body composition changes in patients with systolic heart failure treated with beta blockers: A pilot study

International Journal of Cardiology

Volumn 106, Issue 3, 2006, Pages 319-322

  Lainscak, Mitja ^a   Keber, Irena ^b   Anker, Stefan D ^c,d  

^a General Hospital Murska Sobota   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Beta blockers; Bioimpedance; Body fat mass; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WATER; CACHEXIA; CLINICAL ARTICLE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SYSTOLE; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADRENERGIC BETA-ANTAGONISTS; AGED; BODY COMPOSITION; BODY MASS INDEX; ELECTRIC IMPEDANCE; ENERGY METABOLISM; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SYSTOLE;

EID: 28844438290     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.01.061     Document Type: Article

References (26)

1. J.G.F. Cleland, A. Khand, and A.C. Clark The heart failure epidemic: exactly how big is it? Eur Heart J 22 2001 623 626
2. E.T. Poehlman, J. Scheffers, S.S. Gotlieb, M.L. Fisher, and P. Vaitekevicius Increased resting metabolic rate in patients with congestive heart failure Ann Intern Med 121 1994 860 862
3. T.O. Obisesan, M.J. Toth, and K. Donaldson Energy expenditure and symptom severity in men with heart failure Am J Cardiol 77 1996 1250 1252
4. S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
5. M.C. Shibata, M.D. Flather, and D. Wang Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure Eur J Heart Fail 3 2001 351 359
6. M. Packer, A.J.S. Coats, and M.B. Fowler Effects of carvedilol in severe chronic heart failure N Engl J Med 344 2001 1651 1658
7. T.B. Horwich, G.C. Fonarow, M.A. Hamilton, W.R. MacLean, M.A. Woo, and J.H. Tillisch The relationship between obesity and mortality in patients with heart failure J Am Coll Cardiol 38 2001 789 795
8. C.H. Davos, W. Doehner, and M. Rauchhaus Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity J Card Fail 9 2003 29 35
9. M. Rauchhaus, A.L. Clark, and W. Doehner The relationship between cholesterol and survival in patients with chronic heart failure J Am Coll Cardiol 42 2003 1933 1940
10. T.B. Horwich, M.A. Hamilton, W.R. Maclellan, and G.C. Fonarow Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure J Card Fail 8 2002 216 224
11. C.J. Lavie, A.F. Osman, R.V. Milani, and M.R. Mehra Body composition and prognosis in chronic systolic heart failure: the obesity paradox Am J Cardiol 91 2003 891 894
12. S.D. Anker, A. Negassa, and A.J.S. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
13. S.D. Anker, A.J.S. Coats, E.B. Roecker, A. Scherhag, and M. Packer Does Carvedilol prevent and reverse cardiac cachexia in patients with severe heart failure? Results of the COPERNICUS study Eur Heart J 23 Suppl S 2002 394 [Abstract]
14. S.D. Anker, P. Lechat, and H.J. Dargie Prevention of cachexia in patients with chronic heart failure by bisoprolol: results from the CIBIS-II study J Am Coll Cardiol 41 Suppl A 2003 156A 157A [Abstract]
15. K. Hryniewicz, A.S. Androne, A. Hudaihed, and S.D. Katz Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure J Card Fail 9 2003 464 468
16. A.M. Sharma, T. Pischon, S. Hardt, I. Kunz, and F.C. Luft Beta-adrenergic receptor blockers and weight gain: a systematic analysis Hypertension 37 2001 250 254
17. S.D. Anker, T.P. Chua, and J.W. Swan Hormonal changes and catabolic/anabolic imbalance in chronic heart failure: the importance for cardiac cachexia Circulation 96 1997 526 534
18. G. Paolisso, A. Gambradella, and D. Galzerano Total-body and myocardial substrate utilization in congestive heart failure Metabolism 43 1994 174 179
19. T.R. Wallhaus, M. Taylor, and T.R. DeGrado Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure Circulation 103 2001 2441 2446
20. S. Welle, R.G. Schwartz, and M. Statt Reduced metabolic rate during beta-adrenergic blockade in humans Metabolism 40 1991 619 622
21. A. Astrup, L. Simonsen, J. Bullow, J. Madsen, and N.J. Christensen Epinephrine mediates facultative carbohydrate-induced thermogenesis in human skeletal muscle Am J Physiol 257 1989 E340 E345
22. L. de Jonge, and G.A. Bray The thermic effect of food and obesity: a critical review Obes Res 5 1997 622 631
23. G. Koch, I.W. Franz, and F.W. Lohmann Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma cateholamines at rest and during exercise Clin Sci 61 suppl 7 1981 433s 435s
24. M. Podbregar, and G. Voga Effect of selective and nonselective β-blockers on resting energy production rate and total body substrate utilization in chronic heart failure J Card Fail 8 2002 369 377
25. M. Lainscak Implementation of guidelines for management of heart failure in heart failure clinic: effects beyond pharmacological treatment Int J Cardiol 97 2004 411 416
26. M. Cicoira, W. Doehner, and E. Jankowska Body composition and prognosis in 511 chronic heart failure patients: results from three European centers Eur J Heart Fail Suppl 3 2004 69 [Abstract]